Figure S4 from Endothelial Activation and Blood–Brain Barrier Disruption in Neurotoxicity after Adoptive Immunotherapy with CD19 CAR-T Cells

Abstract

Supplementary Figure 4. Activation of HUVECs by serum from patients with neurotoxicity.